Coronavirus Novavax Is 96% Effective Against COVID-19, Says Company OB Bureau Mar 12, 2021 New Delhi: US-based biotech company Novavax’s COVID-19 vaccine was 96.4 per cent effective against the original strain of the virus in a phase-3 trial in the UK, the company has said.…
